2019 - 2022 Development of new therapeutoc strategy for high-risk chemotherapy-refractory neuroblastoma
2016 - 2019 Establishment of therapeutic strategy for advanced gastrointestinal cancer with targeted alpha therapy
2013 - 2017 Olfactory training in daily diet and imaging analysis for the olfactory nerve regeneration.
2010 - 2015 Targeted radionuclide therapy for malignant neuroendcrine tumors based on biological and pathohistological characteristics
2009 - 2012 Objective olfactory function test with olfactory nerve transport
2008 - 2011 Evaluation of radiotoxicity to lymphocytes after Yttrium-90-labelled monoclonal anti-CD20 antibody therapy
2007 - 2009 Targeted radionuclide therapy for malignant neuroendcrine tumors combined with antiangiogenic therapy : from bench to bedside
2007 - 2009 腫瘍血管新生の可視化を可能にする分子イメージング剤の開発
2007 - 2008 Development and evaluation of novel radiopharmaceuticals which are targeted to sigma receptors for comprehensive cancer therapy
2006 - 2008 Prediction of cancer therapeutic effect with molecular targeting agents by molecular imaging of the signal transduction
2005 - 2007 Radiotoxicity after iodine-131 MIBG therapy using the micronucleus assay
2005 - 2007 ぽすとFDGを担う腫瘍診断用ポジトロン放出核種標識人工アミノ酸製剤の探索
2004 - 2006 The foundational research on "cancer therapy guideline and effect prediction" by the molecular imaging.
2004 - 2006 Development of specific, universal targeted radiotherapy through induction of avidin on cancer cell membrane and internalization of scavenger receptor
Tumor detection and treatment with radiopharmaceuticals
Show all
Papers (398)：
Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami, Kohshin Washiyama, Kenji Mishiro, Hiroshi Wakabayashi, Kazuhiro Takahashi, Seigo Kinuya, Kazuma Ogawa. Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor. European journal of nuclear medicine and molecular imaging. 2024
Kazuma Ogawa, Kota Nishizawa, Kenji Mishiro, Nurmaya Effendi, Takeshi Fuchigami, Masayuki Munekane, Hiroshi Wakabayashi, Seigo Kinuya. Synthesis and Evaluation of Radiogallium Labeled Bone-Imaging Probes Using Oligo-γ-Carboxy Glutamic Acid Peptides as Carriers to Bone. Molecular pharmaceutics. 2024
Tadashi Watabe, Masao Namba, Sachiko Yanagida, Yoshihide Nakamura, Takahiro Yamada, Saori Tatsuno, Aritoshi Ri, Shuhei Yoshida, Kumiko Uyama, Seigo Kinuya, et al. Manual on the proper use of the 211At-labeled PSMA ligand ([211At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition). Annals of Nuclear Medicine. 2024
Xue Zhang, Kenichi Nakajima, Atsushi Mizokami, Hiroyuki Horikoshi, Koshiro Nishimoto, Katsuyoshi Hashine, Hideyasu Matsuyama, Satoru Takahashi, Hiroshi Wakabayashi, Seigo Kinuya. Flare phenomenon visualized by 99mTc-bone scintigraphy has prognostic value for patients with metastatic castration-resistant prostate cancer. Annals of Nuclear Medicine. 2024
Takayuki Shibutani, Masahisa Onoguchi, Takayuki Kanno, Seigo Kinuya. Influence of spill-over for 99mTc images and the effect of scatter correction for dual-isotope simultaneous acquisition with 99mTc and 18F using small-animal SPECT-PET/CT system. Physical and engineering sciences in medicine. 2023
Hiroshi Mori, Hiroshi Wakabayashi, Shintaro Saito, Kenichi Nakajima, Tomo Hiromasa, Satoru Watanabe, Takafumi Yamase, Kotaro Yoshida, Toshifumi Gabata, Seigo Kinuya. Comparisons of detectability between whole-body MRI and I-123/131 mIBG images in patients with metastatic pheochromocytoma and paraganglioma. JOURNAL OF NUCLEAR MEDICINE. 2021. 62
Hiroshi Wakabayashi, Yuka Taniguchi, Masako Yamada, Kei Morino, Akiko Otosaki, Anri Inaki, Daiki Kayano, Satoru Watanabe, Tomo Hiromasa, Hiroshi Mori, et al. Effect of Using Tungsten Apron for Occupational Radiation Exposure in Nurses during Care of I-131-mIBG Therapy for Children with High-risk Neuroblastoma. JOURNAL OF NUCLEAR MEDICINE. 2021. 62
